All News

Today is October 21, 2018. All times in Eastern Daylight Time.

Ipsen Presents Real-World Pancreatic Cancer Data on ONIVYDE® at the European Society for Medical Oncology (ESMO) 2018 Annual Congress

10/21/2018 - 06:45 AM

BUSINESS WIRE
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

10/21/2018 - 06:45 AM

BUSINESS WIRE
Socure Founder to Discuss How AI is Reshaping Digital ID Verification at Money20/20 2018

10/21/2018 - 06:35 AM

BUSINESS WIRE
Smart Link accélère l'expansion de ses services numériques grâce aux solutions Cloud d’Avaya

10/21/2018 - 05:12 AM

BUSINESS WIRE
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer

10/21/2018 - 05:10 AM

BUSINESS WIRE
Genentech’s Investigational Personalized Medicine Entrectinib Shrank Tumors in People with NTRK Fusion-Positive Solid Tumors

10/21/2018 - 05:00 AM

BUSINESS WIRE
Children’s Hospital Los Angeles ‘From Paris With Love’ Gala Raises $5.5 MILLION to Support Pediatric Medical Care and Research

10/21/2018 - 04:19 AM

BUSINESS WIRE
Takeda presenta los resultados del ensayo de fase 3 ALTA-1L que destaca la eficacia intracraneal de ALUNBRIG® (brigatinib) en comparación con crizotinib en el cáncer de pulmón amicrocítico ALK+ avanzado de primera línea

10/20/2018 - 09:20 PM

BUSINESS WIRE
Carson and Assa Abloy’s Mul-T-Lock Announce Partnership and Integration

10/20/2018 - 07:04 PM

BUSINESS WIRE
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting

10/20/2018 - 06:30 PM

BUSINESS WIRE
New Tool Under Development May Help Arthritis Patients Better Assess Risks and Benefits of Treatment Choices, Study Shows

10/20/2018 - 05:30 PM

BUSINESS WIRE
Takeda präsentiert Ergebnisse aus der Phase-3-Studie ALTA-1L, die die intrakranielle Wirksamkeit von ALUNBRIG® (Brigatinib) gegenüber Crizotinib in der Erstlinientherapie beim ALK-positiven...

10/20/2018 - 04:33 PM

BUSINESS WIRE
Statement from the Russian Direct Investment Fund Relating to the Khashoggi Case

10/20/2018 - 01:21 PM

BUSINESS WIRE
Genentech’s Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer

10/20/2018 - 10:30 AM

BUSINESS WIRE
Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer

10/20/2018 - 10:30 AM

BUSINESS WIRE
Medical Society of the District of Columbia Honors Neal Barnard, M.D., F.A.C.C.

10/20/2018 - 10:29 AM

BUSINESS WIRE
Infiniti Research Reveals Five Promising Trends Emerging in the Food Packaging Market

10/20/2018 - 09:31 AM

BUSINESS WIRE
Quantzig Reveals the Challenges Hindering the Adoption of Blockchain in Healthcare

10/20/2018 - 09:27 AM

BUSINESS WIRE
Quantzig Predicts the Future of Bitcoin - Proclaims It a Gamble

10/20/2018 - 09:19 AM

BUSINESS WIRE
First Presentation of Early Data for Merck’s Investigational STING Agonist (MK-1454) in Patients with Advanced Solid Tumors or Lymphomas at ESMO 2018 Congress

10/20/2018 - 09:00 AM

BUSINESS WIRE
Exelixis Announces Results from Two Analyses Evaluating Effect of PD-L1 Expression or Prior Treatment with Checkpoint Inhibitors on Efficacy of Cabozantinib in Patients with Advanced Renal Cell Carcinoma

10/20/2018 - 08:45 AM

BUSINESS WIRE
ImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 Congress

10/20/2018 - 06:30 AM

BUSINESS WIRE
Takeda apresenta resultados do ensaio ALTA-1L de fase 3 que destaca a eficácia intracraniana do ALUNBRIG® (brigatinibe) em relação ao crizotinibe no câncer de pulmão de não pequenas células ALK+ avançado de primeira linha

10/20/2018 - 05:07 AM

BUSINESS WIRE
C5 Capital to Sign Landmark Atlantic Future Forum Accord on Cyber Security and Artificial Intelligence

10/20/2018 - 04:26 AM

BUSINESS WIRE
Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Shows Promising Results in Patients with Advanced Form of Bladder Cancer

10/20/2018 - 03:15 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 691

Next »

Search